| 产品名称 | Peptides EP05805_1 | Tyrosinase 369-377 mutant (HLA-A*02:01) 371D |
|---|---|
| 目录号 | EP05805_1 |
| 别名 | Tyrosinase 369-377 mutant (HLA-A*02:01) 371D |
| 外观 | 见COA |
| 分子量 | N/A |
| CAS | N/A |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| EP05805_1 | 1 mg | 咨询 | 咨询 |
Peptides EP05805_1 | Tyrosinase 369-377 mutant (HLA-A*02:01) 371D
品名：Tyrosinase 369-377 mutant (HLA-A*02:01) 371D
货号：EP05805_1
规格：1 mg
品牌：Peptides.de
产品描述
Antigen Peptide Tyrosinase 369-377 (371D) (HLA-A*02:01) YMDGTMSQV for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays. ingle peptide (YMDGTMSQV) for stimulation of human Gp 100-specific CD8+ T-cells. YMDGTMSQV is a linear peptidic epitope (epitope ID75043) studied as part of Tyrosinase from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assaysAntigen Peptide Tyrosinase 369-377 (371D) (HLA-A*02:01) YMDGTMSQV for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays. ingle peptide (YMDGTMSQV) for stimulation of human Gp 100-specific CD8+ T-cells. YMDGTMSQV is a linear peptidic epitope (epitope ID75043) studied as part of Tyrosinase from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assaysAntigen Peptide Tyrosinase 369-377 (371D) (HLA-A*02:01) YMDGTMSQV for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays. ingle peptide (YMDGTMSQV) for stimulation of human Gp 100-specific CD8+ T-cells. YMDGTMSQV is a linear peptidic epitope (epitope ID75043) studied as part of Tyrosinase from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays
| Protein | Tyrosinase |
| Species | Human |
| Application | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
| Indication | Cancer |
